Rectal Cancer

Part of the Medical Radiology book series (MEDRAD)


Reirradiation combined with chemotherapy for patients developing recurrent rectal cancer after radiation or chemo-radiation is feasible and provides high chances for cure and palliation. Nearly one half of patients with resected disease achieve long-term control of pelvic disease and up to 65% of them can have long-term (5 years) survival. Even in unresected patients, long-term control can be achieved in about 20% of cases with one out of five patients surviving after 5 years. Acute and late toxicity are not prohibitive if proper attention is paid to both radiation technique and surgical technique. Use of small radiation fields, exclusion of bowel and bladder, use of hyperfractionated radiation doses up to 40 Gy are recommended. Since most of treatment failures occur within the radiation treatment field, future studies should investigate methods to further improve local control, such as radiotherapy dose escalation by highly conformal radiotherapy techniques or the combination of radiotherapy with newer chemotherapeutic and biological agents. In view of the fact that about one half of surviving patients will develop distant metastases, innovative strategies for reduction of distant metastases should also be explored.


Rectal Cancer Total Mesorectal Excision Preoperative Radiotherapy Late Toxicity Pelvic Exenteration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Abdel-Wahab MM, Wolfson AH, Raub W et al (1997) The role of hyperfractionated re-irradiation in metastatic brain disease: a single institutional trial. Am J Clin Oncol 20:158–160PubMedCrossRefGoogle Scholar
  2. Adam IJ, Mohamdee MO, Martin IG et al (1994) Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 344:707–711PubMedCrossRefGoogle Scholar
  3. Allum WH, Mack P, Priestman TJ et al (1987) Radiotherapy for pain relief in locally recurrent colorectal cancer. Ann R Coll Surg Engl 69:220–221PubMedGoogle Scholar
  4. Barkin J, Cohen M, Flaxman M (1988) Value of routine follow-up endoscopy for the detection of recurrent colorectal cancer. Am J Gastroenterol 88:1355–1360Google Scholar
  5. Beets-Tan RG, Beets GL (2004) Rectal cancer: review with emphasis on MR imaging. Radiology 232:335–346PubMedCrossRefGoogle Scholar
  6. Beets-Tan RG, Beets GL, Borstlap AC et al (2000) Preoperative assessment of local tumor extent in advanced rectal cancer: CT or high-resolution MRI? Abdom Imaging 25:533–541PubMedCrossRefGoogle Scholar
  7. Bentzen SM, Baumann M (2002) The linear-quadratic model in clinical practice. In: Steal GG (ed) Basic clinical radiobiology. Arnold, London, pp 134–146Google Scholar
  8. Bosset JF, Calais G, Mineur L et al (2005) Enhanced tumoricidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results—EORTC 22921. J Clin Oncol 23:5620–5627PubMedCrossRefGoogle Scholar
  9. Bouchard P, Efron J (2010) Management of recurrent rectal cancer. Ann Surg Oncol 17:1343–1356PubMedCrossRefGoogle Scholar
  10. Braendengen M, Tveit KM, Berglund A et al (2008) Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 26:3687–3694PubMedCrossRefGoogle Scholar
  11. Brown G (2005) Thin section MRI in multidisciplinary pre-operative decision making for patients with rectal cancer. Br J Radiol 78:S117–S127PubMedCrossRefGoogle Scholar
  12. Camilleri-Brennan J, Steele RJ (2001) The impact of recurrent rectal cancer on quality of life. Eur J Surg Oncol 27:349–353PubMedCrossRefGoogle Scholar
  13. Chan CL, Bokey EL, Chapuis PH et al (2006) Local recurrence after curative resection for rectal cancer is associated with anterior position of the tumour. Br J Surg 93:105–112PubMedCrossRefGoogle Scholar
  14. Das P, Delclos ME, Skibber JM et al (2010) Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation. Int J Radiat Oncol Biol Phys 77:60–65PubMedCrossRefGoogle Scholar
  15. Delbeke D, Vitola J, Sandler M et al (1997) Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 38:1196–1201PubMedGoogle Scholar
  16. den Dulk M, Marijnen CA, Putter H et al (2007) Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. J Ann Surg 246:83–90CrossRefGoogle Scholar
  17. Dresen RC, Gosens MJ, Martijn H et al (2008) Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol 15:1937–1947PubMedCrossRefGoogle Scholar
  18. Enker WE (1997) Total mesorectal excision—the new golden standard of surgery for rectal cancer. Ann Med 29:127–133PubMedGoogle Scholar
  19. Enker WE, Thaler HT, Cranor ML et al (1995) Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 181:335–346PubMedGoogle Scholar
  20. Farouk R, Nelson H, Radice E et al (1998) Accuracy of computed tomography in determining resectability for locally advanced primary or recurrent colorectal cancers. Am J Surg 175:283–287PubMedCrossRefGoogle Scholar
  21. Fowler JF (1989) The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62:679–694PubMedCrossRefGoogle Scholar
  22. Francois Y, Nemoz CJ, Baulieux J et al (1999) Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 17:2396PubMedGoogle Scholar
  23. Frykholm GJ, Pahlman L, Glimelius B (1995) Treatment of local recurrences of rectal carcinoma. Radiother Oncol 34:185–194PubMedCrossRefGoogle Scholar
  24. Gerard JP, Conroy T, Bonnetain F et al (2006) Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 28:4620–4625CrossRefGoogle Scholar
  25. Glimelius B (2003) Recurrent rectal cancer. The pre-irradiated primary tumour: can more radiotherapy be given? Colorectal Dis 5:501–503PubMedCrossRefGoogle Scholar
  26. Glynne-Jones R, Saunders MI, Hoskin P et al (1999) A pilot study of continuous, hyperfractionated, accelerated radiotherapy in rectal adenocarcinoma. Clin Oncol 11:334–339CrossRefGoogle Scholar
  27. Glynne-Jones R, Mawdsley S, Pearce T et al (2006) Alternative clinical endpoints in rectal cancer: are we getting closer? Ann Oncol 17:1239–1248PubMedCrossRefGoogle Scholar
  28. Goldberg PA, Nicholls RJ, Porter NH et al (1994) Long-term results of a randomised trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer: reduction in local treatment failure. Eur J Cancer 30A:1602–1606PubMedCrossRefGoogle Scholar
  29. Grabbe E, Winkler R (1985) Local recurrence after sphinctersaving resection for rectal and rectosigmoid carcinoma. Value of various diagnostic methods. Radiology 155:305–310PubMedGoogle Scholar
  30. Gunderson LL, Nelson H, Martenson JA et al (1996) Intraoperative electron and external beam irradiation with or without 5-fluorouracil and maximum surgical resection for previously unirradiated locally recurrent colorectal cancer. Dis Colon Rectum 39:1379–1395PubMedCrossRefGoogle Scholar
  31. Gunderson LL, Nelson H, Martenson JA et al (1997) Locally advanced primary colorectal cancer: intraoperative electron and external beam irradiation +/− 5-FU. Int J Radiat Oncol Biol Phys 37:601–614PubMedCrossRefGoogle Scholar
  32. Haddock MG, Gunderson LL, Nelson H et al (2001) Intraoperative irradiation for locally recurrent colorectal cancer in previously irradiated patients. Int J Radiat Oncol Biol Phys 49:1267–1274PubMedCrossRefGoogle Scholar
  33. Heald RJ (1995) Total mesorectal excision is optimal surgery for rectal cancer: a Scandinavian consensus. Br J Surg 82:1297–1299PubMedCrossRefGoogle Scholar
  34. Hoffman JP, Riley L, Carp NZ et al (1993) Isolated locally recurrent rectal cancer: a review of incidence, presentation, and management. Semin Oncol 20:506–519PubMedGoogle Scholar
  35. Kalff V, Hicks R, Ware R et al (2002) The clinical impact of 18F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study. J Nucl Med 43:492–499PubMedGoogle Scholar
  36. Kapiteijn E, Marijnen CA, Nagtegaal ID et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638–646PubMedCrossRefGoogle Scholar
  37. Kavanagh BD, Pan CC, Dawson LA et al (2010) Radiation dose–volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys 76:S101–S107PubMedCrossRefGoogle Scholar
  38. Kusters M, van de Velde CJ, Beets-Tan RG et al (2009) Patterns of local recurrence in rectal cancer: a single-center experience. Ann Surg Oncol 16:289–296PubMedCrossRefGoogle Scholar
  39. Lai D, Fulham M, Stephens M et al (1996) The role of wholebody positron emission tomography with F-18 fluorodeoxyglucose in recurrent colorectal cancer metastases to the liver. Arch Surg 131:703–707PubMedCrossRefGoogle Scholar
  40. Lee YT (1995) Local and regional recurrence of carcinoma of the colon and rectum: I. Tumour-host factors and adjuvant therapy. Surg Oncol 4:283–293PubMedCrossRefGoogle Scholar
  41. MacFarlane JK, Ryall RD, Heald RJ (1993) Mesorectal excision for rectal cancer. Lancet 341:457–460PubMedCrossRefGoogle Scholar
  42. Mannaerts GH, Rutten HJ, Martijn H et al (2001) Comparison of intraoperative radiation therapy-containing multimodality treatment with historical treatment modalities for locally recurrent rectal cancer. Dis Colon Rectum 44:1749–1758PubMedCrossRefGoogle Scholar
  43. Marijnen CA, Nagtegaal ID, Klein Kranenbarg E et al (2001) No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 19:1976–1984PubMedGoogle Scholar
  44. Marijnen CA, Nagtegaal ID, Kapiteijn E et al (2003) Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys 55:1311–1320PubMedCrossRefGoogle Scholar
  45. Messiou C, Chalmers AG, Boyle K et al (2008) Preoperative MR assessment of recurrent rectal cancer. Br J Radiol 81:468–473PubMedCrossRefGoogle Scholar
  46. Mohiuddin M, Lingareddy V, Rakinic J et al (1993) Reirradiation for rectal cancer and surgical resection after ultra high doses. Int J Radiat Oncol Biol Phys 27:1159–1163PubMedCrossRefGoogle Scholar
  47. Mohiuddin M, Marks G, Marks J (2002) Long-term results of reirradiation for patients with recurrent rectal carcinoma. Cancer 95:1144–1150PubMedCrossRefGoogle Scholar
  48. Moore HG, Shoup M, Riedel E et al (2004) Colorectal cancer pelvic recurrences: determinants of resectability. Dis Colon Rectum 47:1599–1606PubMedCrossRefGoogle Scholar
  49. Moriya Y (2006) Treatment strategy for locally recurrent rectal cancer. Jpn J Clin Oncol 36:127–131PubMedCrossRefGoogle Scholar
  50. Nieder C, Milas L, Ang KK (2000) Tissue tolerance to reirradiation. Semin Radiat Oncol 10:200–209PubMedCrossRefGoogle Scholar
  51. Ogunbiyi O, Flanagan F, Dehdashti F et al (1997) Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol 4:613–620PubMedCrossRefGoogle Scholar
  52. Pacelli F, Tortorelli AP, Rosa F et al (2010) Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy. Ann Surg Oncol 17:152–162PubMedCrossRefGoogle Scholar
  53. Pacini P, Cionini L, Pirtoli L et al (1986) Symptomatic recurrences of carcinoma of the rectum and sigmoid. The influence of radiotherapy on the quality of life. Dis Colon Rectum 29:865–868PubMedCrossRefGoogle Scholar
  54. Palmer G, Martling A, Cedermark B et al (2006) A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol 15:3109–3117CrossRefGoogle Scholar
  55. Quirke P, Durdey P, Dixon MF et al (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: histopathological study of lateral tumour spread and surgical excision. Lancet 2:996–999PubMedCrossRefGoogle Scholar
  56. Rödel C, Grabenbauer GG, Matzel KE et al (2000) Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer. Dis Colon Rectum 43:312–319PubMedCrossRefGoogle Scholar
  57. Saito N, Koda K, Takiguchi N et al (2003) Curative surgery for local pelvic recurrence of rectal cancer. Dig Surg 20:192–199PubMedCrossRefGoogle Scholar
  58. Suzuki K, Gunderson LL, Devine RM et al (1995) Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer. Cancer 75:939–952PubMedCrossRefGoogle Scholar
  59. Suzuki K, Dozois RR, Devine RM et al (1996) Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum 39:730–736PubMedCrossRefGoogle Scholar
  60. Swedish Rectal Cancer Trial (1996) Local recurrence rate in a randomised multicentre trial of preoperative radiotherapy compared with operation alone in resectable rectal carcinoma. Eur J Surg 162:397–402Google Scholar
  61. Temple WJ, Saettler EB (2000) Locally recurrent rectal cancer: role of composite resection of extensive pelvic tumors with strategies for minimizing risk of recurrence. J Surg Oncol 73:47–58PubMedCrossRefGoogle Scholar
  62. Tepper JE, Gunderson LL, Orlow E et al (1984) Complications of intraoperative radiation therapy. Int J Radiat Oncol Biol Phys 10:1831–1839PubMedCrossRefGoogle Scholar
  63. Valentini V, Morganti AG, Gambacorta MA et al (2006) Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: a multicentric phase II study. Int J Radiat Oncol Biol Phys 64:1129–1139PubMedCrossRefGoogle Scholar
  64. Valentini V, Aristei C, Glimelius B et al (2009) Multidisciplinary rectal cancer management: 2nd European Rectal Cancer Consensus Conference. Radiother Oncol 92:148–163PubMedCrossRefGoogle Scholar
  65. van den Brink M, Stiggelbout AM, van den Hout WB et al (2004) Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without preoperative radiotherapy. J Clin Oncol 22:3958–3964PubMedCrossRefGoogle Scholar
  66. Vermaas M, Ferenschild FT, Nuyttens JJ et al (2005) Preoperative radiotherapy improves outcome in recurrent rectal cancer. Dis Colon Rectum 48:918–928PubMedCrossRefGoogle Scholar
  67. Vermaas M, Nuyttens JJ, Ferenschild FT et al (2008) Reirradiation, surgery and IORT for recurrent rectal cancer in previously irradiated patients. Radiother Oncol 87:357–360PubMedCrossRefGoogle Scholar
  68. Vitola J, Delbeke D, Sandler M et al (1996) Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 171:21–26PubMedCrossRefGoogle Scholar
  69. Wanebo HJ, Gaker DL, Whitehill R et al (1987) Pelvic recurrence of rectal cancer: options for curative resection. Ann Surg 205:482–495PubMedCrossRefGoogle Scholar
  70. Wanebo HJ, Antoniuk P, Koness RJ et al (1999) Pelvic resection of recurrent rectal cancer: technical considerations and outcomes. Dis Colon Rectum 42:1438–1448PubMedCrossRefGoogle Scholar
  71. Ward B, Miller D, Frank J (1989) Prospective evaluation of hepatic imaging studies in the detection of colorectal metastases: correlation with surgical findings. Surgery 105:180–187PubMedGoogle Scholar
  72. Wieder HA, Rosenberg R, Lordick F et al (2007) Rectal cancer: MR imaging before neoadjuvant chemotherapy and radiation therapy for prediction of tumor-free circumferential resection margins and long-term survival. Radiology 243:744–751PubMedCrossRefGoogle Scholar
  73. Wiggers T, de Vries MR, Veeze-Kuypers B (1996) Surgery for local recurrence of rectal carcinoma. Dis Colon Rectum 39:323–328PubMedCrossRefGoogle Scholar
  74. Yamada K, Ishizawa T, Niwa K et al (2001) Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg 88:988–993PubMedCrossRefGoogle Scholar
  75. Yamada K, Ishizawa T, Niwa K et al (2002) Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer. Dis Colon Rectum 45:1078–1084PubMedCrossRefGoogle Scholar
  76. Yiu R, Wong SK, Cromwell J et al (2001) Pelvic wall involvement denotes a poor prognosis in T4 rectal cancer. Dis Colon Rectum 44:1676–1681PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  1. 1.Cattedra di RadioterapiaUniversità Cattolica S. CuoreRomeItaly

Personalised recommendations